Objective This study was undertaken to evaluate efficacy and long-term safety of triheptanoin in patients >1 year old, not on a ketogenic diet, with drug-resistant seizures associated with glucose transporter 1 deficiency syndrome (Glut1DS). Methods UX007G-CL201 was a randomized, double-blind, placebo-controlled trial. Following a 6-week...
-
2022 (v1)PublicationUploaded on: February 11, 2024
-
2022 (v1)Publication
Clinical manifestations in STXBP1 developmental and epileptic encephalopathy (DEE) vary in severity and outcome, and the genotypic spectrum is diverse. We aim to trace the neurodevelopmental trajectories in individuals with STXBP1-DEE and dissect the relationship between neurodevelopment and epilepsy.
Uploaded on: February 14, 2024